Skip to main content

Advertisement

Log in

Quantitative Assessment of the Hepatic Metabolic Volume Product in Patients with Diffuse Hepatic Steatosis and Normal Controls Through Use of FDG-PET and MR Imaging: A Novel Concept

  • Brief Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Aims and Objectives

The aim of this study was to compare hepatic standardized uptake values (SUVs) and hepatic metabolic volumetric products (HMVP) between patients of diffuse hepatic steatosis and control subjects with normal livers.

Materials and Methods

Twenty-seven subjects were included in the study (13 men and 14 women; age range, 34–72 years). All had 18F-2-fluoro-2-D-deoxyglucose-positron emission tomography (FDG-PET) and magnetic resonance imaging (MRI) scans with an interscan interval of 0–5 months. Twelve of 27 subjects had diffuse hepatic steatosis on MRI. The remaining 15 were selected as age-matched controls based on normal liver parenchyma on MRI. Mean and maximum hepatic SUVs were calculated for both patient groups on FDG-PET images. Hepatic volumes were measured from MRI. HMVP in each subject was subsequently calculated by multiplication of hepatic volume by mean hepatic SUV. HMVPs as well as mean and maximum hepatic SUVs were compared between the two study groups.

Results

HMVPs, mean hepatic SUVs, and maximum hepatic SUVs were greater (statistically significant, p < 0.05) in subjects with diffuse hepatic steatosis compared to those in the control group.

Conclusion

The increase in HMVP is the result of increased hepatic metabolic activity likely related to the diffuse hepatic steatosis. The active inflammatory process related to the diffuse hepatic steatosis is the probable explanation for the increase in hepatic metabolic activity on FDG-PET study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wanless IR, Shiota K (2004) The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 24:99–106

    Article  PubMed  Google Scholar 

  2. Lalor PF, Faint J, Aarbodem Y, Hubscher SG et al (2007) The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 27:173–193

    Article  CAS  PubMed  Google Scholar 

  3. Harrison SA, Kadakia S, Lang KA et al (2002) Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 97:2714–2724

    CAS  PubMed  Google Scholar 

  4. McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521–533

    Article  PubMed  Google Scholar 

  5. Spahr L, Hadengue A (2005) Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management. Rev Med Suisse 7(1):2032–2034

    Google Scholar 

  6. Saadeh S, Younossi ZM, Remer EM et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745–750

    Article  PubMed  Google Scholar 

  7. van Hoek B (2004) Non-alcoholic fatty liver disease: a brief review. Scand J Gastroenterol 241:56–59

    Article  Google Scholar 

  8. El-Haddad G, Zhuang H, Gupta N et al (2004) Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med 34:313–329

    Article  PubMed  Google Scholar 

  9. Zhuang H, Alavi A (2002) 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32:47–59

    Article  PubMed  Google Scholar 

  10. Siegelman ES, Rosen MA (2001) Imaging of hepatic steatosis. Semin Liver Dis 21:71–80

    Article  CAS  PubMed  Google Scholar 

  11. Itai Y, Saida Y (2002) Pitfalls in liver imaging. Eur Radiol 12:1162–1174

    Article  PubMed  Google Scholar 

  12. Mortele KJ, Ros PR (2001) Imaging of diffuse liver disease. Semin Liver Dis 21:195–212

    Article  CAS  PubMed  Google Scholar 

  13. Siegelman ES (1997) MR imaging of diffuse liver disease. Hepatic fat and iron. Magn Reson Imaging Clin N Am 5:347–365

    CAS  PubMed  Google Scholar 

  14. Choi S, Diehl AM (2005) Role of inflammation in nonalcoholic steatohepatitis. Curr Opin Gastroenterol 21:702–707

    Article  PubMed  Google Scholar 

  15. Day CP, James OF (2005) Steatohepatitis: a tale of two “hits”? Curr Opin Gastroenterol 21:702–707

    Article  Google Scholar 

  16. Haque M, Sanyal AJ (2002) The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 16:709–731

    Article  CAS  PubMed  Google Scholar 

  17. Feldstein AE, Canbay A, Angulo P et al (2003) Hepatocyte apoptosis and fas expression are prominent features of human non-alcoholic steatohepatitis. Gastroenterology 125:437–443

    Article  PubMed  Google Scholar 

  18. Feldstein AE, Werneburg NW, Canbay A et al (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40:185–194

    Article  CAS  PubMed  Google Scholar 

  19. Valenti L, Fracanzani AL, Dongiovanni P et al (2002) Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122:274–280

    Article  CAS  PubMed  Google Scholar 

  20. Wigg AJ, Roberts-Thomson IC, Dymock RB et al (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206–211

    Article  CAS  PubMed  Google Scholar 

  21. Hui JM, Hodge A, Farrell GC et al (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40(1):46–54

    Article  CAS  PubMed  Google Scholar 

  22. McCuskey RS, Ito Y, Robertson GR et al (2004) Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 40:386–393

    Article  PubMed  Google Scholar 

  23. Zhuang H, Yu JQ, Alavi A (2005) Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 43:121–134

    Article  PubMed  Google Scholar 

  24. Busetto L, Tregnaghi A, De Marchi F et al (2002) Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res 10:408–411

    Article  PubMed  Google Scholar 

  25. Tchelepi H, Ralls PW, Radin R, Grant E (2002) Sonography of diffuse liver disease. J Ultrasound Med 21:1023–1032

    PubMed  Google Scholar 

  26. Nomura F, Ohnishi K, Ochiai T, Okuda K (1987) Obesity-related nonalcoholic fatty liver: CT features and follow-up studies after low-calorie diet. Radiology 162:845–847

    CAS  PubMed  Google Scholar 

  27. Fishbein MH, Gardner KG, Potter CJ et al (1997) Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 15:287–293

    Article  CAS  PubMed  Google Scholar 

  28. Qayyum A, Goh JS, Kakar S et al (2005) Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques—initial experience. Radiology 237:507–511

    Article  PubMed  Google Scholar 

  29. Lupsor M, Badea R (2005) Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy? Rom J Gastroenterol 14:419–425

    PubMed  Google Scholar 

  30. Chave G, Milot L, Pilleul F (2005) Out of phase magnetic resonance imaging and liver applications. J Radiol 86(9 Pt 1):993–997

    Article  CAS  PubMed  Google Scholar 

  31. Das K, Kar P (2005) Non-alcoholic steatohepatitis. J Assoc Phys India 53:195–199

    CAS  Google Scholar 

  32. Fishbein M, Mogren J, Mogren C et al (2005) Undetected hepatomegaly in obese children by primary care physicians: a pitfall in the diagnosis of pediatric nonalcoholic fatty liver disease. Clin Pediatr (Phila) 44:135–141

    Article  Google Scholar 

  33. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43(2 Suppl 1):S99–S112

    Article  CAS  PubMed  Google Scholar 

  34. Yki-Järvinen H (2005) Fat in the liver and insulin resistance. Ann Med 37:347–356

    Article  PubMed  Google Scholar 

  35. Bugianesi E, Zannoni C, Vanni E et al (2004) Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liver Dis 36:165–173

    Article  CAS  PubMed  Google Scholar 

  36. Burke A, Lucey MR (2004) Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 4:686–693

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abass Alavi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bural, G.G., Torigian, D.A., Burke, A. et al. Quantitative Assessment of the Hepatic Metabolic Volume Product in Patients with Diffuse Hepatic Steatosis and Normal Controls Through Use of FDG-PET and MR Imaging: A Novel Concept. Mol Imaging Biol 12, 233–239 (2010). https://doi.org/10.1007/s11307-009-0258-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-009-0258-4

Key words

Navigation